Skip to Main Content

Author Details

Matthew B Rettig
David Geffen School of Medicine, University of California los angeles
1995
136
48
PMIDPaper TitleJournal TitlePublished Year
37802226Long-Term Quality-of-Life Outcomes After Prostate Radiation Therapy With or Without High-Dose-Rate Brachytherapy Boost: Post Hoc Analysis of TROG 03.04 RADAR.Int J Radiat Oncol Biol Phys2024
35058580Significant changes in macrophage and CD8 T cell densities in primary prostate tumors 2 weeks after SBRT.Prostate Cancer Prostatic Dis2023
37815914MYC is a regulator of androgen receptor inhibition-induced metabolic requirements in prostate cancer.Cell Rep2023
37639648Biochemical Recurrence Surrogacy for Clinical Outcomes After Radiotherapy for Adenocarcinoma of the Prostate.J Clin Oncol2023
37289025The Genomic and Epigenomic Landscape of Double-Negative Metastatic Prostate Cancer.Cancer Res2023
37009941Quantitative assessment of PSMA PET response to therapy in castration-sensitive prostate cancer using an automated imaging platform for disease identification and measurement.Eur J Hybrid Imaging2023
36966268Race-dependent association of clinical trial participation with improved outcomes for high-risk prostate cancer patients treated in the modern era.Prostate Cancer Prostatic Dis2023
37432081Response Evaluation Criteria in PSMA PET/CT (RECIP 1.0) in Metastatic Castration-resistant Prostate Cancer.Radiology2023
36723856Multimodality Therapies for Localized Prostate Cancer.Curr Oncol Rep2023
36870853Transcriptomic Heterogeneity in High-risk Prostate Cancer and Implications for Extraprostatic Disease at Presentation on Prostate-specific Membrane Antigen Positron Emission Tomography.Eur Urol Oncol2023
36797449LUNAR: a randomized Phase 2 study of <sup>177</sup> Lutetium-PSMA Neoadjuvant to Ablative Radiotherapy for Oligorecurrent Prostate Cancer (clinical trial protocol).BJU Int2023
36797143Better Late than Never for Late Toxicity Assessment.Eur Urol2023
36863416Patterns of Failure in Men With Radiorecurrent Prostate Cancer: A Post Hoc Analysis of 3 Prospective Gallium 68 Prostate-Specific Membrane Antigen Positron Emission Tomography/Computed Tomography Imaging Trials.Int J Radiat Oncol Biol Phys2023
36179990External Beam Radiation Therapy With or Without Brachytherapy Boost in Men With Very-High-Risk Prostate Cancer: A Large Multicenter International Consortium Analysis.Int J Radiat Oncol Biol Phys2023
36269935Sequencing of Androgen-Deprivation Therapy of Short Duration With Radiotherapy for Nonmetastatic Prostate Cancer (SANDSTORM): A Pooled Analysis of 12 Randomized Trials.J Clin Oncol2023
36007724Quality-of-Life Outcomes and Toxicity Profile Among Patients With Localized Prostate Cancer After Radical Prostatectomy Treated With Stereotactic Body Radiation: The SCIMITAR Multicenter Phase 2 Trial.Int J Radiat Oncol Biol Phys2023
34049980aPROMISE: A Novel Automated PROMISE Platform to Standardize Evaluation of Tumor Burden in <sup>18</sup>F-DCFPyL Images of Veterans with Prostate Cancer.J Nucl Med2022
35579581Factors that guide selection among androgen receptor inhibitors in patients with nonmetastatic castration-resistant prostate cancer: Q&amp;A.Clin Adv Hematol Oncol2022
35579579How patient characteristics can guide selection among androgen receptor inhibitors in patients with nonmetastatic castration-resistant prostate cancer.Clin Adv Hematol Oncol2022
35579577Factors that guide selection among androgen receptor inhibitors in patients with nonmetastatic castration-resistant prostate cancer.Clin Adv Hematol Oncol2022
35469702High-dose Radiotherapy or Androgen Deprivation Therapy (HEAT) as Treatment Intensification for Localized Prostate Cancer: An Individual Patient-data Network Meta-analysis from the MARCAP Consortium.Eur Urol2022
35602518A Population-Level Analysis of the Protective Effects of Androgen Deprivation Therapy Against COVID-19 Disease Incidence and Severity.Front Med (Lausanne)2022
35422442Novel Framework for Treatment Response Evaluation Using PSMA PET/CT in Patients with Metastatic Castration-Resistant Prostate Cancer (RECIP 1.0): An International Multicenter Study.J Nucl Med2022
36109521Transcriptional profiling of matched patient biopsies clarifies molecular determinants of enzalutamide-induced lineage plasticity.Nat Commun2022
35934601Local Failure Events in Prostate Cancer Treated with Radiotherapy: A Pooled Analysis of 18 Randomized Trials from the Meta-analysis of Randomized Trials in Cancer of the Prostate Consortium (LEVIATHAN).Eur Urol2022
35929009Ordering and Interpreting Precision Oncology Studies for Adults With Advanced Solid Tumors: A Primer.Fed Pract2022
36251389The 5-Hydroxymethylcytosine Landscape of Prostate Cancer.Cancer Res2022
33602654Identifying the Best Candidates for Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography as the Primary Staging Approach Among Men with High-risk Prostate Cancer and Negative Conventional Imaging.Eur Urol Oncol2022
35051385Androgen deprivation therapy use and duration with definitive radiotherapy for localised prostate cancer: an individual patient data meta-analysis.Lancet Oncol2022
35050303Interplay Between Duration of Androgen Deprivation Therapy and External Beam Radiotherapy With or Without a Brachytherapy Boost for Optimal Treatment of High-risk Prostate Cancer: A Patient-Level Data Analysis of 3 Cohorts.JAMA Oncol2022
34463809Analytical performance of aPROMISE: automated anatomic contextualization, detection, and quantification of [<sup>18</sup>F]DCFPyL (PSMA) imaging for standardized reporting.Eur J Nucl Med Mol Imaging2022
34400799Radiation therapy dose and androgen deprivation therapy in localized prostate cancer: a meta-regression of 5-year outcomes in phase III randomized controlled trials.Prostate Cancer Prostatic Dis2022
34774650Refining the definition of biochemical failure in the era of stereotactic body radiation therapy for prostate cancer: The Phoenix definition and beyond.Radiother Oncol2022
31411981Underutilization of Androgen Deprivation Therapy with External Beam Radiotherapy in Men with High-grade Prostate Cancer.Eur Urol Oncol2021
35289808Highlights in prostate cancer from the 2021 European Society for Medical Oncology Congress and the 2021 American Urological Association Meeting: commentary.Clin Adv Hematol Oncol2021
34902034Performance of a Prostate-Specific Membrane Antigen Positron Emission Tomography/Computed Tomography-Derived Risk-Stratification Tool for High-risk and Very High-risk Prostate Cancer.JAMA Netw Open2021
34964855Comparison of Response to Definitive Radiotherapy for Localized Prostate Cancer in Black and White Men: A Meta-analysis.JAMA Netw Open2021
34246328Nomograms to predict outcomes after <sup>177</sup>Lu-PSMA therapy in men with metastatic castration-resistant prostate cancer: an international, multicentre, retrospective study.Lancet Oncol2021
33985797Patterns of Clinical Progression in Radiorecurrent High-risk Prostate Cancer.Eur Urol2021
34196715Comparison of Multimodal Therapies and Outcomes Among Patients With High-Risk Prostate Cancer With Adverse Clinicopathologic Features.JAMA Netw Open2021
34225789Hormonal intervention for the treatment of veterans with COVID-19 requiring hospitalization (HITCH): a multicenter, phase 2 randomized controlled trial of best supportive care vs best supportive care plus degarelix: study protocol for a randomized controlled trial.Trials2021
33309278A Systematic Review and Meta-analysis of Local Salvage Therapies After Radiotherapy for Prostate Cancer (MASTER).Eur Urol2021
32647353The intraprostatic immune environment after stereotactic body radiotherapy is dominated by myeloid cells.Prostate Cancer Prostatic Dis2021
32424106Transcriptional profiling identifies an androgen receptor activity-low, stemness program associated with enzalutamide resistance.Proc Natl Acad Sci U S A2020
34258585Accelerating precision medicine in metastatic prostate cancer.Nat Cancer2020
31996731Arctigenin inhibits prostate tumor growth in high-fat diet fed mice through dual actions on adipose tissue and tumor.Sci Rep2020
31924715Impact of <sup>68</sup>Ga-PSMA-11 PET/CT on Staging and Management of Prostate Cancer Patients in Various Clinical Settings: A Prospective Single-Center Study.J Nucl Med2020
31745256Germline polymorphisms associated with impaired survival outcomes and somatic tumor alterations in advanced prostate cancer.Prostate Cancer Prostatic Dis2020
31718822Local Failure and Survival After Definitive Radiotherapy for Aggressive Prostate Cancer: An Individual Patient-level Meta-analysis of Six Randomized Trials.Eur Urol2020
33028635Dysregulation of hsa-miR-34a and hsa-miR-449a leads to overexpression of PACS-1 and loss of DNA damage response (DDR) in cervical cancer.J Biol Chem2020
  • 1 - 50 of 136

Recommended Authors

Pedro Isaacsson Velho
Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins
Career Start Year 2013
Number of shared co-authors 25
Sungyong You
Cedars-Sinai Medical Center
Career Start Year 2008
Number of shared co-authors 37
Anne Haegert
University of British Columbia
Career Start Year 2008
Number of shared co-authors 29
Arun A Azad
Peter MacCallum Cancer Centre
Career Start Year 2007
Number of shared co-authors 18
Alan H Bryce
Mayo Clinic
Career Start Year 2006
Number of shared co-authors 32
Aruz Mesci
Juravinski Cancer Centre
Career Start Year 2006
Number of shared co-authors 1
Alok K Tewari
Dana-Farber Cancer Institute, Harvard Medical School
Career Start Year 2005
Number of shared co-authors 10
Hui Xue
Agricultural Genomics Institute at Shenzhen, Chinese Academy of Agricultural Sciences
Career Start Year 2005
Number of shared co-authors 35
Robert H Bell
University of British Columbia
Career Start Year 2004
Number of shared co-authors 27
Pavlos Msaouel
The University of Texas MD Anderson Cancer Center
Career Start Year 2004
Number of shared co-authors 4
Eleni Efstathiou
Houston Methodist Cancer Center
Career Start Year 2000
Number of shared co-authors 46
Pingfu Fu
Case Western Reserve University
Career Start Year 2000
Number of shared co-authors 3
Martijn P Lolkema
Erasmus MC Cancer Institute
Career Start Year 1999
Number of shared co-authors 16
Anthony M Joshua
The Kinghorn Cancer Centre, St. Vincent's Hospital Sydney
Career Start Year 1997
Number of shared co-authors 29
Evan Y Yu
University of Washington and Fred Hutchinson Cancer Research Center
Career Start Year 1997
Number of shared co-authors 69
Michael A Carducci
Johns Hopkins School of Medicine
Career Start Year 1995
Number of shared co-authors 65
Stanley K Liu
Odette Cancer Centre, University of Toronto
Career Start Year 1995
Number of shared co-authors 9
Ganesh V Raj
University of Texas Southwestern Medical Center at Dallas
Career Start Year 1994
Number of shared co-authors 40
Bhaskar Kallakury
Georgetown University
Career Start Year 1993
Number of shared co-authors 6
David I Quinn
USC Norris Comprehensive Cancer Center
Career Start Year 1993
Number of shared co-authors 27
Urban Emmenegger
Odette Cancer Centre
Career Start Year 1991
Number of shared co-authors 14
Christopher M Hovens
Royal Melbourne Hospital, The University of Melbourne
Career Start Year 1989
Number of shared co-authors 19
Javed Siddiqui
Michigan Center for Translational Pathology, University of Michigan ann arbor
Career Start Year 1988
Number of shared co-authors 49
Massimo Loda
Weill Medical College of Cornell University
Career Start Year 1984
Number of shared co-authors 59
Oliver Sartor
Tulane University School of Medicine
Career Start Year 1983
Number of shared co-authors 85
David M Nanus
Sandra and Edward Meyer Cancer Center
Career Start Year 1983
Number of shared co-authors 47
David M Berman
Queen's University
Career Start Year 1982
Number of shared co-authors 14
Kenneth J Pienta
The Brady Urological Institute, Johns Hopkins University School of Medicine
Career Start Year 1981
Number of shared co-authors 91
Philip W Kantoff
Memorial Sloan Kettering Cancer Center
Career Start Year 1981
Number of shared co-authors 82
Howard I Scher
Memorial Sloan Kettering Cancer Center
Career Start Year 1973
Number of shared co-authors 71

Collaborators

Robert E Reiter
David Geffen School of Medicine at university of california los angeles
Co-authored papers 49
Nicholas G Nickols
University of California, Veteran Affairs Greater Los Angeles Healthcare System
Co-authored papers 41
Amar U Kishan
University of California los angeles
Co-authored papers 38
Felix Y Feng
UCSF Medical Center-Mount Zion
Co-authored papers 31
Michael L Steinberg
University of California los angeles
Co-authored papers 30
Daniel E Spratt
University Hospitals Seidman Cancer Center, Case Western Reserve University
Co-authored papers 24
Jeremie Calais
university of california los angeles
Co-authored papers 20
Jiaoti Huang
Duke University School of Medicine
Co-authored papers 20
David Elashoff
David Geffen School of Medicine at University of California los angeles
Co-authored papers 18
Eric J Small
University of California san francisco
Co-authored papers 17
Tomasz M Beer
OHSU Knight Cancer Institute, Oregon Health & Science University
Co-authored papers 17
Martin E Gleave
University of British Columbia
Co-authored papers 16
Rahul Aggarwal
University of California San Francisco
Co-authored papers 16
Joshi J Alumkal
Rogel Cancer Center, University of Michigan ann arbor
Co-authored papers 16
Ting Martin Ma
University of Washington
Co-authored papers 15
Tahmineh Romero
David Geffen School of Medicine at university of california los angeles
Co-authored papers 14
Adam Foye
University of California San Francisco
Co-authored papers 14
Christopher P Evans
University of California Davis
Co-authored papers 14
Johannes Czernin
university of california los angeles
Co-authored papers 14
Paul C Boutros
University of California los angeles
Co-authored papers 12
Patrick A Kupelian
university of california los angeles Medical Center
Co-authored papers 11
Tristan Grogan
University of California Los Angeles
Co-authored papers 11
Nicholas G Zaorsky
University Hospitals Seidman Cancer Centre, Cleveland Medical Centre
Co-authored papers 11
Owen N Witte
University of California los angeles
Co-authored papers 11
Kim N Chi
University of British Columbia
Co-authored papers 10
David A Quigley
University of California-San Francisco
Co-authored papers 10
Primo N Lara
University of California Davis Comprehensive Cancer Center
Co-authored papers 10
Robert T Dess
University of Michigan ann arbor
Co-authored papers 9
Joshua M Stuart
University of California at Santa Cruz
Co-authored papers 9
Thomas M Pisansky
Mayo Clinic
Co-authored papers 9
Release 1.2